Literature DB >> 6150642

Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans.

U Keller, P P Gerber, W Stauffacher.   

Abstract

Elevation of plasma norepinephrine concentrations to stress levels (1,800 pg/ml) resulted in normal subjects in a significant increase in ketone body production by 155% (determined by use of [14C]acetoacetate infusions), in a decrease of the metabolic clearance rate by 38%, hyperketonemia, and in increased plasma free fatty acid (FFA) levels by 57% after 75 min. Norepinephrine infusion during somatostatin-induced insulin deficiency resulted in an augmented and sustained increase in ketone body concentrations due to increased production and decreased peripheral clearance of ketone bodies. Norepinephrine's stimulatory effect on lipolysis waned with time, and its effect on ketogenesis in normal subjects was greater than its influence on plasma FFA levels, and thus presumably on hepatic FFA uptake, suggesting a direct stimulatory effect on hepatic ketogenesis. The data demonstrate that in normal humans the hyperketonemic effect of elevated plasma norepinephrine concentrations results from a combination of three factors: increased ketone body production from augmented FFA supply to the liver; accelerated hepatic ketogenesis; and modestly decreased metabolic clearance of ketone bodies. Acute insulin deficiency augments all these effects and results in progressive ketosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150642     DOI: 10.1152/ajpendo.1984.247.6.E732

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Diabetic ketoacidosis: current views on pathogenesis and treatment.

Authors:  U Keller
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

Review 2.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

3.  Beta-adrenergic blockade restores glucose's antiketogenic activity after exercise in carbohydrate-depleted athletes.

Authors:  J H Adams; G Irving; J H Koeslag; J D Lochner; R C Sandell; C Wilkinson
Journal:  J Physiol       Date:  1987-05       Impact factor: 5.182

4.  Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes.

Authors:  Thomas H Meek; Miles E Matsen; Vincent Damian; Alex Cubelo; Streamson C Chua; Gregory J Morton
Journal:  Endocrinology       Date:  2014-08-19       Impact factor: 4.736

5.  The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.

Authors:  A Avogaro; A Valerio; L Gnudi; A Maran; M Miola; E Duner; C Marescotti; E Iori; A Tiengo; R Nosadini
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

6.  Amphetamine-Like Analogues in Diabetes: Speeding towards Ketogenesis.

Authors:  Natalia M Branis; Steven D Wittlin
Journal:  Case Rep Endocrinol       Date:  2015-04-19

7.  Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study.

Authors:  Nora Luethi; Luca Cioccari; Marco Crisman; Rinaldo Bellomo; Glenn M Eastwood; Johan Mårtensson
Journal:  Crit Care       Date:  2016-09-15       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.